The grey market is signalling strong investor interest in the Molbio Diagnostics IPO, with the latest grey market premium (GMP) standing at around ₹138 per share.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.